| [1] |
中国医药生物技术协会药物性肝损伤防治技术专业委员会,中华医学会肝病学分会药物性肝病学组. 中国药物性肝损伤诊治指南(2023年版)[J].中华肝脏病杂志, 2023, 31(4): 355-384.
|
| [2] |
Shen T, Liu Y X, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology, 2019, 156(8): 2230-2241.e11. DOI: 10.1053/j.gastro.2019.02.002.
|
| [3] |
李容容,李盟,罗琼, 等. 国内外药物性肝损伤临床诊疗指南的比较分析[J]. 中华肝脏病杂志, 2023, 31(4): 433-439.
|
| [4] |
闫潇,邓毅,马骏, 等. 顺铂毒性损伤机制及中药防治机制的研究进展[J]. 中国实验方剂学杂志, 2021, 27(5): 233-242.
|
| [5] |
Coşkun Ö, Öztopuz Ö, Büyük B. Possible protective activity of n-acetyl cysteine against cisplatin-induced hepatotoxicity in rats[J]. Mol Biol Rep, 2021, 48(1): 637-644. DOI: 10.1007/s11033-020-06111-0.
|
| [6] |
Nie C Q, Ding X, Rong R, et al. Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats[J]. Life Sci, 2021, 272: 119248. DOI: 10.1016/j.lfs.2021.119248.
|
| [7] |
Korovljev D, Stajer V, Ostojic J, et al. Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial[J]. Clin Res Hepatol Gastroenterol, 2019, 43(6): 688-693.
|
| [8] |
|
| [9] |
张昭,魏娅楠,仪杨, 等. 水相中氢气浓度检测方法的建立[J]. 生物技术进展, 2020, 10(2): 158-163.
|
| [10] |
朱珊珊,陈鑫,颜巧妍, 等. 抗肿瘤药物的临床应用进展[J]. 中国现代医生, 2019, 57(9): 164-168.
|
| [11] |
Sami D H, Soliman A S, Khowailed A A, et al. The protective effect of 7-hydroxycoumarin against cisplatin-induced liver injury is mediated via attenuation of oxidative stress and inflammation and upregulation of Nrf2/HO-1 pathway[J]. Environ Sci Pollut Res Int, 2023, 30(33): 80181-80191. DOI: 10.1007/s11356-023-27879-1.
|
| [12] |
Slezak J, Kura B, Lebaron T W, et al. Oxidative stress and pathways of molecular hydrogen effects in medicine[J]. Curr Pharm Des, 2021, 27(5): 610-625. DOI: 10.2174/1381612826666200821114016.
|
| [13] |
Xia C X, Liu W W, Zeng D X, et al. Effect of hydrogen-rich water on oxidative stress, liver function, and viral load in patients with chronic hepatitis B[J]. Clin Transl Sci, 2013, 6(5): 372-375.
|
| [14] |
Tao G R, Zhang G J, Chen W, et al. A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease[J]. J Cell Mol Med, 2022, 26(14): 4113-4123. DOI: 10.1111/jcmm.17456.
|
| [15] |
Zhang Y X, Bi M M, Chen Z F, et al. Hydrogen gas alleviates acute alcohol-induced liver injury by inhibiting JNK activation[J]. Exp Ther Med, 2021, 21(5): 453. DOI: 10.3892/etm.2021.9884.
|
| [16] |
T/CAS 500-2021富氢包装饮用水[S].
|
| [17] |
Rahman M H, Jeong E S, You H S, et al. Redox-mechanisms of molecular hydrogen promote healthful longevity[J]. Antioxidants, 2023, 12(5): 988. DOI: 10.3390/antiox12050988.
|
| [18] |
Zhang X Y, Tao G R, Zhao Y N, et al. Molecular hydrogen inhibits colorectal cancer growth via the AKT/SCD1 signaling pathway[J]. Biomed Res Int, 2022, 2022: 8024452. DOI: 10.1155/2022/8024452.
|
| [19] |
周兴,李雪梅,李晓辉. 以线粒体为靶点治疗肝损伤的研究进展[J]. 重庆理工大学学报(自然科学版), 2021, 35(9): 184-193.
|
| [20] |
Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J]. Nat Med, 2007, 13(6): 688-694. DOI: 10.1038/nm1577.
|
| [21] |
Sumbalová Z, Kucharská J, Rausová Z, et al. The effect of adjuvant therapy with molecular hydrogen on endogenous coenzyme Q10 levels and platelet mitochondrial bioenergetics in patients with non-alcoholic fatty liver disease[J]. Int J Mol Sci, 2023, 24(15): 12477.
|
| [22] |
Yamagishi N, Yamamoto Y, Nishi T, et al. Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway[J]. PLoS One, 2023, 18(6): e0287788.
|